The ultimate goal of an RNA-Seq study is not to generate tables, figures, or p-values.
The goal is to answer a biological question.
After differential expression analysis and functional enrichment analysis have been completed, researchers must determine what conclusions are supported by the available evidence.
This chapter focuses on transforming results into defensible biological claims while acknowledging uncertainty, limitations, and study context.
flowchart TD
A[Functional Enrichment Results]
subgraph BI["Biological Interpretation"]
B[Evidence Synthesis]
C[Biological Claims]
end
D[Reproducible Reporting]
A --> B --> C --> Dflowchart TD
A[Functional Enrichment Results]
subgraph BI["Biological Interpretation"]
B[Evidence Synthesis]
C[Biological Claims]
end
D[Reproducible Reporting]
A --> B --> C --> D
This chapter represents the final stage of Biological Interpretation.
A common mistake is to treat statistical results as biological conclusions.
For example:
GeneA is significantly upregulated.This is a statistical observation.
It is not yet a biological claim.
The interpretation process requires additional reasoning.
Consider the following sequence:
GeneA is upregulated
↓
GeneA participates in immune signaling
↓
Immune-related pathways are enriched
↓
Evidence suggests immune activationEach step adds biological context.
The final interpretation depends on multiple sources of evidence rather than a single result.
Biological interpretation often combines:
No single source of evidence is usually sufficient on its own.
A simplified reasoning chain might look like:
Treatment Group
↓
Differentially Expressed Genes
↓
Immune-Related Pathways Enriched
↓
Consistent Expression Patterns
↓
Evidence Supports Immune ActivationThe strength of the claim depends on the strength of the supporting evidence.
Different conclusions carry different levels of certainty.
The treatment was associated with
increased expression of immune-related genes.The treatment may influence immune activity.The treatment activates the immune system.The final statement may not be fully supported by the available evidence.
RNA-Seq studies often identify associations.
Researchers should be careful not to imply causation unless the study design supports causal inference.
For example:
Preferred:
Gene expression was associated with treatment.Less appropriate:
Treatment caused gene activation.The distinction matters.
Interpretation should be evaluated against biological knowledge.
Questions include:
Biological plausibility strengthens interpretation but does not guarantee correctness.
Stronger conclusions often emerge when multiple lines of evidence agree.
For example:
Differential Expression
+
Pathway Enrichment
+
Metadata
+
Published LiteratureWhen independent sources point in the same direction, confidence may increase.
Every RNA-Seq study contains uncertainty.
Potential sources include:
Good interpretation acknowledges uncertainty rather than hiding it.
Every study has limitations.
Examples include:
Limitations should be discussed explicitly.
Results:
235 genes differentially expressedEnrichment:
Immune response pathways enrichedInterpretation:
The treatment was associated with
coordinated expression changes involving
immune-related pathways.This claim is stronger than simply listing significant genes and more cautious than asserting direct causation.
Before writing conclusions, ask:
These questions improve scientific reasoning.
Common mistakes include:
Strong analysis can still produce weak conclusions if interpretation is poor.
Before finalizing conclusions, confirm that:
A useful CDI reasoning structure is:
Biological Question
↓
Statistical Evidence
↓
Functional Interpretation
↓
Evidence Synthesis
↓
Biological Claim
↓
Limitations & UncertaintyThis framework encourages transparent and defensible interpretation.
At this stage, the RNA-Seq workflow moves from interpretation to communication.
Differential Expression Results
↓
Functional Enrichment Analysis
↓
Evidence Synthesis
↓
Biological Claims
↓
Reproducible ReportingThe next section focuses on documenting and communicating these conclusions reproducibly.
Biological claims should emerge from a structured reasoning process that integrates statistical evidence, biological context, enrichment results, study design, and uncertainty.
The most valuable RNA-Seq analyses are not those that generate the most significant genes, but those that produce conclusions that are transparent, defensible, and reproducible.
The next chapter begins the Reproducible Reporting section, where analyses, figures, methods, and conclusions are organized into a transparent and reusable scientific report.